Pavel Mozgunov
Scholar

Pavel Mozgunov

Google Scholar ID: nj0wzIUAAAAJ
Programme Leader Track at MRC Biostatistics Unit
Early Phase Clinical TrialsAdaptive DesignsMedical StatisticsBiostatisticsDose Finding
Google Scholar↗
Citations & Impact
All-time
Citations
833
 
H-index
14
 
i10-index
20
 
Publications
20
 
Co-authors
6
list available
Contact
No contact links provided.
Publications
7 items
A Bayesian Phase I/II basket design with robust information borrowing to identify subtrial-specific optimal biological doses
2026
Cited
0
Sample size reassessment in Bayesian hybrid clinical trials
2025
Cited
0
U-DESPE: a Bayesian Utility-based methodology for dosing regimen optimization in early-phase oncology trials based on Dose-Exposure, Safety, Pharmacodynamics, Efficacy
2025
Cited
0
Using joint models in phase I dose-finding designs in oncology: considerations for frequentist approaches
2025
Cited
0
An information metric for comparing and assessing informative interim decisions in sequential clinical trials
2025
Cited
0
On the interplay between prior weight and variance of the robustification component in Robust Mixture Prior Bayesian Dynamic Borrowing approach
2025
Cited
0
Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy
2025
Cited
0
Resume (English only)
Co-authors
6 total
Thomas Jaki
Thomas Jaki
Professor of Statistics, University of Regensburg and University of Cambridge
Co-author 2
Co-author 2
Mark Kelbert
Mark Kelbert
Professor of Higher School of Economics
Co-author 4
Co-author 4
Mauro Gasparini
Mauro Gasparini
Unknown affiliation
Enrico Bibbona
Enrico Bibbona
Politecnico di Torino